|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/68 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3250610 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16744204.5 |
| Date of filing the European patent application | 2016-01-29 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation | 2023-09-25 |
| (86) | Number | PCT/US2016/015720 |
| Date | 2016-01-29 |
| (87) | Number | WO 2016/123521 |
| Date | 2016-08-04 |
| (30) | Number | Date | Country code |
| 201562110071 P | 2015-01-30 | US | |
| 201562258082 P | 2015-11-20 | US |
| (72) |
KEHRY, Marilyn , US
KING, David, J. , US
LING, Leona, E. , US
MEADOR, James III , US
ROY, Sucharita , US
MANNING, Anthony , US
|
| (73) |
Momenta Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | FcRn antikūnai ir jų panaudojimo būdai |
| FCRN ANTIBODIES AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-12-18 | 11 | 289.00 EUR |
| 2027-01-29 |